Showing results (141-150 of 2,103) with videos related to
Sort By:
Pageof 211
CA: a Cancer Journal for Clinicians|July 28, 2006
Targeted therapy of cancer: new prospects for antibodies and immunoconjugatesRobert M Sharkey, David M GoldenbergCancer Investigation|February 10, 2006
Advances in radioimmunotherapy in the age of molecular engineering and pretargetingRobert M Sharkey, David M GoldenbergThe Urologic Clinics of North America|May 1, 1984
Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphataseD M Goldenberg, F H DeLandArchives Internationales De Pharmacodynamie Et De Therapie|July 1, 1977
Anti-inflammatory activity of EU-2972, 2-(3,4-dichlorphenylamino)quinolizinium bromideM M Goldenberg, A C IlseSurgical Neurology|February 1, 1994
Usefulness of a fiber optic Swan-Ganz catheter to monitor oxygen transport during volume expansion in a patient with ischemic neurologic deficits from aneurysmal subarachnoid hemorrhageM B Pritz, T M GoldenbergJournal of Medicinal Chemistry|November 1, 1975
2-(3,4-Dichloroanilino)quinolizinium bromide, a unique antispasmodic, antisecretory, and antiulcerogenic agentR J Alaimo, M M GoldenbergJournal of Pharmaceutical Sciences|August 1, 1978
Synthesis and antiulcerogenic evaluation of 2-(substituted phenylimino)-2H-quinolizinesR J Alaimo, M M GoldenbergJournal of Computer Assisted Tomography|August 1, 1984
Nonspecificity of intraparenchymal blood-fluid levels in cerebral computed tomographyS Spiegel, N Just, M GoldenbergCancer Research|August 1, 1980
Immunological considerations in the use of goat antibodies to carcinoembryonic antigen for the radioimmunodetection of cancerF J Primus, D M GoldenbergEuropean Journal of Nuclear Medicine and Molecular Imaging|February 13, 2008
Therapy of human carcinoma xenografts with antibodies to EGFr and HER-2 conjugated to radionuclides emitting low-energy electronsM Jules Mattes, David M GoldenbergPageof 211